Difference between revisions of "Clinical decision support improves physician guideline adherence for laboratory monitoring of chronic kidney disease: a matched cohort study"
From Clinfowiki
(→Appendix) |
(→References) |
||
Line 16: | Line 16: | ||
* Effect of CDSS on achievement of guideline targets for LDL cholesterol (a) and 25-D (b). <ref name="LDL cholesterol"> Effect of CDSS on achievement of guideline targets for LDL cholesterol (a) and 25-D (b). http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608162/figure/Fig4/</ref> | * Effect of CDSS on achievement of guideline targets for LDL cholesterol (a) and 25-D (b). <ref name="LDL cholesterol"> Effect of CDSS on achievement of guideline targets for LDL cholesterol (a) and 25-D (b). http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608162/figure/Fig4/</ref> | ||
* Estimated odds ratio for achieving guideline-recommended laboratory test targets: CDSS vs Controls. <ref name="Achieving CDSS vs Controls"> Estimated odds ratio for achieving guideline-recommended laboratory test targets: CDSS vs Controls. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608162/table/Tab4/ </ref> | * Estimated odds ratio for achieving guideline-recommended laboratory test targets: CDSS vs Controls. <ref name="Achieving CDSS vs Controls"> Estimated odds ratio for achieving guideline-recommended laboratory test targets: CDSS vs Controls. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608162/table/Tab4/ </ref> | ||
+ | |||
+ | == My Comments == | ||
== References == | == References == |
Revision as of 01:51, 22 October 2015
Background
Methods
Results
Conclusions
Appendix
- Lab measurement frequency and range targets used in the analysis. [1]
- Baseline patient characteristics. [2]
- Estimated odds ratio for ordering laboratory tests within guideline-recommended intervals: CDSS vs Controls. [3]
- Effect of CDSS on adherence to guideline testing intervals for eGFR. [4]
- Effect of CDSS on adherence to guideline testing intervals for phosphorus (a) and PTH (b). [5]
- Effect of CDSS on adherence to guideline testing intervals for LDL-C (a) and Urine Panels (b). [6]
- Effect of CDSS on achievement of guideline targets for LDL cholesterol (a) and 25-D (b). [7]
- Estimated odds ratio for achieving guideline-recommended laboratory test targets: CDSS vs Controls. [8]
My Comments
References
- ↑ Lab measurement frequency and range targets used in the analysis. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608162/table/Tab1/
- ↑ Baseline patient characteristics http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608162/table/Tab2/
- ↑ http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608162/table/Tab3/
- ↑ Effect of CDSS on adherence to guideline testing intervals for eGFR. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608162/figure/Fig1/
- ↑ Effect of CDSS on adherence to guideline testing intervals for phosphorus (a) and PTH (b). http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608162/figure/Fig2/
- ↑ Effect of CDSS on adherence to guideline testing intervals for LDL-C (a) and Urine Panels (b). http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608162/figure/Fig3/
- ↑ Effect of CDSS on achievement of guideline targets for LDL cholesterol (a) and 25-D (b). http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608162/figure/Fig4/
- ↑ Estimated odds ratio for achieving guideline-recommended laboratory test targets: CDSS vs Controls. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608162/table/Tab4/